OTCMKTS:RPBC - Redpoint Bio Stock Price, News, & Analysis Sign in or create an account to add this stock to your watchlist. Get Started $0.0014 0.00 (0.00 %) (As of 09/25/2018 07:14 AM ET)Previous Close$0.0020Today's Range$0.0010 - $0.001452-Week Range$0.0006 - $0.0023Volume10,400 shsAverage Volume15,169 shsMarket Capitalization$110,000.00P/E RatioN/ADividend YieldN/ABeta-1.54 Company ProfileDiscussionChartEarnings HistoryHeadlinesSocial Media Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email Redpoint Bio Corporation, a development stage biotechnology company, focuses on the development of healthier foods and new approaches for the treatment of diabetes and obesity by understanding the biology of taste and its relationship to metabolism, satiety, and diabetes. It enters into a license and commercialization agreement with International Flavors and Fragrances Inc. for the development, manufacture, use, and commercialization of RP44, which is a component of the stevia plant that works as a sweetness enhancer amplifying the existing sugary sweetness in a food or beverage. The company is based in Philadelphia, Pennsylvania. Receive RPBC News and Ratings via Email Sign-up to receive the latest news and ratings for RPBC and its competitors with MarketBeat's FREE daily newsletter. Industry, Sector and Symbol Stock Exchange OTCMKTS Industry Commercial physical research Sub-IndustryN/A SectorMedical SymbolOTCMKTS:RPBC CUSIPN/A Webwww.redpointbio.com Phone215-456-2312 Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Price-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / CashN/A Book ValueN/A Price / BookN/A Profitability EPS (Most Recent Fiscal Year)N/A Net IncomeN/A Net MarginsN/A Return on EquityN/A Return on AssetsN/A Miscellaneous EmployeesN/A Outstanding Shares79,920,000Market Cap$110,000.00 Redpoint Bio (OTCMKTS:RPBC) Frequently Asked Questions What is Redpoint Bio's stock symbol? Redpoint Bio trades on the OTCMKTS under the ticker symbol "RPBC." Who are some of Redpoint Bio's key competitors? Some companies that are related to Redpoint Bio include Iqvia (IQV), Incyte (INCY), EXACT Sciences (EXAS), Icon (ICLR), PRA Health Sciences (PRAH), Charles River Laboratories Intl. (CRL), Syneos Health (SYNH), Exelixis (EXEL), BTG (BTGGF), Medpace (MEDP), Intrexon (XON), National Research (NRCIB), National Research (NRCIA), Sorrento Therapeutics (SRNE) and Eloxx Pharmaceuticals (ELOX). Who are Redpoint Bio's key executives? Redpoint Bio's management team includes the folowing people: Dr. R. Kyle Palmer Ph.D., Sr. Director of Discovery Research How do I buy shares of Redpoint Bio? Shares of RPBC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab. What is Redpoint Bio's stock price today? One share of RPBC stock can currently be purchased for approximately $0.0014. How big of a company is Redpoint Bio? Redpoint Bio has a market capitalization of $110,000.00. What is Redpoint Bio's official website? The official website for Redpoint Bio is http://www.redpointbio.com. How can I contact Redpoint Bio? Redpoint Bio's mailing address is 7 GRAPHICS DRIVE, EWING NJ, 08628. The company can be reached via phone at 215-456-2312. MarketBeat Community Rating for Redpoint Bio (OTCMKTS RPBC)Community Ranking: 2.6 out of 5 ( )Outperform Votes: 31 (Vote Outperform)Underperform Votes: 29 (Vote Underperform)Total Votes: 60MarketBeat's community ratings are surveys of what our community members think about Redpoint Bio and other stocks. Vote "Outperform" if you believe RPBC will outperform the S&P 500 over the long term. Vote "Underperform" if you believe RPBC will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 9/25/2018 by MarketBeat.com StaffFeatured Article: What is the Dow Jones Industrial Average (DJIA)?